IP Library Granted Patent US 8,859,716
Granted Patent B2
US 8,859,716 · App. 13/951,268 · Granted Oct 14, 2014

Degradable thiol-ene polymers

Inventors: Christopher Bowman (Boulder, CO); Kristi Anseth (Boulder, CO); Bilge Hacioglu (Boulder, CO); Charlie Nuttelman (Boulder, CO)
Assignee: The Regents of the University of Colorado
A61L27/18C08G75/045C08G81/00C08G2261/126C08L81/02A61L27/52C08L71/02C08L2205/05A61L27/16Y10S524/916Y10S525/936
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,716
App. No.
13/951,268
Granted
Oct 14, 2014
Kind
B2
Abstract

A thiol-ene polymeric material is disclosed. The material is produced by the photopolymerization of reactants having thiol and olefin moieties. The material can incorporate encapsulated components, including cells. Additionally, the material can be derivatized by reacting the polymeric material with components such as proteins.

Claims (14)

1. A hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer comprising a —C—C— moiety derived from an olefinic portion of a norbornene moiety.

2. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 1 , wherein the —C—C— moiety derived from an olefinic portion of a norbornene moiety is linked to a polymeric moiety selected from the group consisting of poly(lactic acid) (PLA); polyglycolide (PGA); a copolymer of PLA and PGA (PLGA); poly(vinyl alcohol) (PVA); poly(ethylene glycol) (PEG); poly(ethylene oxide); a poly(ethylene oxide)-co-poly(propylene oxide) block copolymer; a poloxamine; a polyanhydride; a polyorthoester; a poly(hydroxy acids); a polydioxanone; a polycarbonate; a polyaminocarbonate; a poly(vinyl pyrrolidone); a poly(ethyl oxazoline); a carboxymethyl cellulose; a hydroxyalkylated cellulose; a polypeptide; a polysaccharide; a carbohydrate; heparan sulfate; chondroitin sulfate; heparin, alginate; and a combination thereof.

3. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 1 , wherein the —C—C— moiety derived from an olefinic portion of a norbornene moiety is bound to a sulfur atom derived from a thiol moiety to provide a moiety of the formula —S—C≡C—.

4. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 3 , wherein the sulfur atom derived from a thiol moiety is linked to a polymeric moiety selected from the group consisting of poly(lactic acid) (PLA); polyglycolide (PGA); a copolymer of PLA and PGA (PLGA); poly(vinyl alcohol) (PVA); poly(ethylene glycol) (PEG); poly(ethylene oxide); a poly(ethylene oxide)-co-poly(propylene oxide) block copolymer; a poloxamine; a polyanhydride; a polyorthoester; a poly(hydroxy acids); a polydioxanone; a polycarbonate; a polyaminocarbonate; a poly(vinyl pyrrolidone); a poly(ethyl oxazoline); a carboxymethyl cellulose; a hydroxyalkylated cellulose; a polypeptide; a polysaccharide; a carbohydrate; heparan sulfate; chondroitin sulfate; heparin, alginate; and a combination thereof.

5. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 3 , wherein sulfur atom is derived from a branched thiol moiety.

6. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 1 , further comprising at least one biologically active component encapsulated within the polymer.

7. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 6 , wherein the biologically active component is selected from the group consisting of cells, tissues, and tissue aggregates.

8. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 6 , wherein the biologically active component is selected from the group consisting of chondrocytes, immortalized cell lines, stem cells, hormone-producing cells and fibroblasts.

9. The hydrogel comprising a biocompatible crosslinked degradable thiol-ene polymer of claim 1 , further comprising at least one pharmacologically active agent encapsulated within the polymer.

10. The hydrogel comprising a biocompatible cross-linked degradable thiol-ene polymer of claim 1 , wherein the polymer is derivatized with a functional molecule selected from the group consisting of adhesion peptides, growth factors, hormones, antihormones, signaling compounds, serum proteins, albumins, macroglobulins, globulins, agglutinins, lectins, antibodies, antigens, enzymes and extracellular matrix proteins.

11. The hydrogel comprising a biocompatible cross-linked degradable thiol-ene polymer of claim 1 , wherein the polymer comprises a segment selected from the group consisting of a moiety of poly(lactic acid) (PLA), polyglycolide (PGA), copolymers of PLA and PGA (PLGA), poly(vinyl alcohol)(PVA), poly(ethylene glycol)(PEG), poly(ethylene oxide), poly(ethylene oxide)-co-poly(propylene oxide) block copolymers, polyoxamines, polyanhydrides, polyorthoesters, poly(hydroxyl acids), polydioxanones, polycarbonates, polyaminocarbonates, poly(vinyl pyrrolidone), poly(ethyl oxazoline), carboxymethyl cellulose, a hydroxyalkylated cellulose, a polypeptide, a polysaccharide, a carbohydrate, heparin sulfate, chondroitin sulfate, heparin, alginate, gelatin, collagen, albumin and ovalbumin.

12. The hydrogel comprising a biocompatible cross-linked degradable thiol-ene polymer of claim 11 , wherein the segment has a molecular weight ranging from about 30 Da to about 50,000 Da.

13. The hydrogel comprising a biocompatible cross-linked degradable thiol-ene polymer of claim 11 , wherein the segment is biodegradable.

14. The hydrogel comprising a biocompatible cross-linked degradable thiol-ene polymer of claim 11 , wherein the polymer comprises a PLA, PVA or PEG segment.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 26, 2015
From: UNIVERSITY OF COLORADO
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 035710/0985 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2013
From: BOWMAN, CHRISTOPHER; ANSETH, KRISTI; HACIOGLU, BILGE; NUTTELMAN, CHARLIE
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 031243/0545 →
Continuity (5)
Continuation 12556640 · Sep 10, 2009
Division 11858062 · Sep 19, 2007
Division 10269916 · Oct 10, 2002
Provisional Application 60328669 · Oct 10, 2001
Related Publication 20140039085A1 · Feb 6, 2014